CCL3 and COVID-19: Accordingly, B12-induced downregulation of CCL3 (C-C Motif Chemokine Ligand 3) strongly and negatively correlates with the hypermethylation of CpGs in its regulatory regions, proving that pharmacological modulation of epigenetic markings in leukocytes positively regulates central components of COVID-19 pathophysiology [138].